SCIENTIFIC PROGRAMME
SESSION I
HOW I TREAT
SMOLDERING MYELOMA
(SMM)
SESSION II
HOW I TREAT NEWLY
DIAGNOSED MULTIPLE
MYELOMA
SESSION III
FROM RISK
STRATIFICATION TO
RISK-BASED THERAPY?
DEBATE 1
SHOULD WE USE MRD
TESTING TO DETERMINE
THERAPY IN MULTIPLE
MYELOMA?
DEBATE 2
IS THERE A FUTURE ROLE
OF AUTOLOGOUS STEM
CELL TRANSPLANTATION?
SESSION IV
HOW I TREAT RELAPSED
MULTIPLE MYELOMA
DEBATE 3
SHOULD EVERY PATIENT
RECEIVE DARATUMUMAB
IN FIRST LINE?
ROUNDTABLE
MULTIPLE MYELOMA
FROM THE PERSPECTIVE
OF FDA/EMEA AND
FOUNDATIONS
SESSION V
YOU CAN’T BE IMMUNE
FOR IMMUNE THERAPY
ANYMORE
SESSION VI
OTHER PLASMA CELL
DYSCRASIAS
KEYNOTE LECTURES
THE FUTURE OF
MULTIPLE MYELOMA
SELECTED ABSTRACTS
FOR AN ORAL
PRESENTATION
ABSTRACTS SELECTED
AS POSTERS
DISCLOSURES
K. RAMASAMY Janssen Research Support, Scientific Advisory Board, Other
Celgene - BMS Research Support, Speakers' Bureau, Scientific Advisory Board, Other
Amgen Research Support, Scientific Advisory Board, Other
Takeda Research Support, Speakers' Bureau, Scientific Advisory Board, Other
L. RASCHE Sanofi Speakers' Bureau, Scientific Advisory Board
Janssen Speakers' Bureau, Scientific Advisory Board
BMS Speakers' Bureau, Scientific Advisory Board
Oncopeptides Speakers' Bureau, Scientific Advisory Board
GSK Speakers' Bureau, Scientific Advisory Board
Skyline Dx Research Support
P. RODRIGUEZ-OTERO Celgene - BMS Consultant, Speakers' Bureau, Scientific Advisory Board
Janssen Consultant, Speakers' Bureau, Scientific Advisory Board
Amgen Speakers' Bureau
Sanofi Speakers' Bureau, Scientific Advisory Board
GSK Consultant, Speakers' Bureau, Scientific Advisory Board
Oncopeptides Scientific Advisory Board
Abbvie Scientific Advisory Board
Kite Pharma Scientific Advisory Board
F. SCHJESVOLD Amgen Research Support, Consultant, Scientific Advisory Board
Mundipharma Consultant, Scientific Advisory Board
BMS / Celgene Research Support, Consultant, Scientific Advisory Board
Teva Consultant
Takeda Consultant, Scientific Advisory Board
Abbvie Consultant
Janssen Research Support, Consultant, Scientific Advisory Board
Novartis Consultant, Scientific Advisory Board
Skyline Dx Consultant
Oncopeptides Research Support, Consultant, Scientific Advisory Board
Sanofi Research Support, Consultant, Scientific Advisory Board
GSK Research Support, Scientific Advisory Board
Pfizer Scientific Advisory Board
Bayer Scientific Advisory Board
Adaptive Scientific Advisory Board
MSD Scientific Advisory Board
N. SHAH Celgene / BMS Research Support
Janssen Research Support
Bluebird Bio Research Support
Sutro Research Support
Biopharma Research Support
Teneobio Research Support
Poseida Research Support
Nektar Research Support
GSK Consultant
Amgen Consultant
Sanofi Consultant
CareDx Consultant
Kite Consultant
Karyopharm Consultant
Oncopeptides Consultant
Indapta Therapeutics Scientific Advisory Board
E. SMITH BMS Research Support, Scientific Advisory Board, Royalties
Fate Therapeutics Consultant
Precision Biosciences Consultant
Chimeric Therapeutics Consultant
N. VAN DE DONK BMS / Celgene Research Support, Scientific Advisory Board
Janssen Research Support, Scientific Advisory Board
Amgen Research Support, Scientific Advisory Board
Takeda Scientific Advisory Board
Novartis Scientific Advisory Board
Bayer Scientific Advisory Board
Servier Scientific Advisory Board
Roche Scientific Advisory Board
J. VOS Celgene Travel Support
Sanofi Scientific Advisory Board
E. ZAMAGNI BMS Scientific Advisory Board, Honoraria
Takeda Scientific Advisory Board, Honoraria
Sanofi Scientific Advisory Board, Honoraria
Amgen Scientific Advisory Board, Honoraria
Janssen Scientific Advisory Board, Honoraria
GSK Scientific Advisory Board, Honoraria
Karyopharm Scientific Advisory Board, Honoraria
S. ZWEEGMAN Janssen Research Support, Scientific Advisory Board
Celgene Scientific Advisory Board
Takeda Research Support, Scientific Advisory Board
Sanofi Scientific Advisory Board
BMS Scientific Advisory Board
Oncopeptides Scientific Advisory Board